Protocol of a drug-drug interaction study between bictegravir/emtricitabine/tenofovir alafenamide and feminizing hormones in trans women living with HIV.
Lacombe-Duncan A, Tseng A, Scarsi KK, Senneker T, Kluger H, Persad Y, Underhill A, Kennedy VL, Armstrong I, Fung R, Bourns A, Nguyen Q, Hranilovic S, Weisdorf T, Chan L, Kia H, Halpenny R, Iyer H, Jeyarajah N, Kovchazov G, Tharao W, Loutfy M.
Lacombe-Duncan A, et al. Among authors: armstrong i.
Br J Clin Pharmacol. 2024 Oct;90(10):2349-2359. doi: 10.1111/bcp.16162. Epub 2024 Jul 11.
Br J Clin Pharmacol. 2024.
PMID: 38992893